If a pharmaceutical company aims to reduce inflammation by targeting the NF-κB signaling pathway, which consequence involving cytokine production is most likely?

💡 Explanation

Inhibiting the NF-κB pathway reduces the expression of genes encoding pro-inflammatory cytokines like TNF-α and IL-6, because NF-κB is a key transcription factor for these cytokines. Therefore, the transcription of pro-inflammatory cytokines will decrease, rather than increase other inflammatory mediators like prostaglandins.

• An individual undergoes chemotherapy, which affects rapidly dividing cells, including those in bone marrow and hair follicles. Which consequence related to cellular aging becomes most prominent following treatment?
• Why does consumption of resistant starch lead to increased butyrate production in the colon, while simple sugars do not?
• Which outcome impairs stability when negative feedback loops regulate thyroid?
• Which failure mode becomes likely when an antibiotic drug concentration gradient exists within a bacterial biofilm due to outer membrane porin mutation?
• If a football player shows signs of concussion during a game, what physiological rationale underlies the immediate removal from play dictated by the concussion protocol?
• If a patient with normal vision undergoes a procedure that selectively damages the horizontal cells in their retina, which consequence follows?